Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Trimeris

1993 FOUNDED
PUBLIC STATUS
101-200 EMPLOYEES
TRMS STOCK SYMBOL
Description

Developer of commercial applications of antiviral drug treatments that utilize a class of fusion inhibitors.The company develops novel anti human immunodeficiency virus therapeutics.

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Medical Supplies
Stock Exchange
NAS
Primary Office
  • 2530 Meridian Parkway
  • Second Floor
  • Durham, NC 27713
  • United States

+1 (919) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Trimeris’s full profile, request a free trial.

Trimeris Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Trimeris‘s full profile, request access.

Request full access to PitchBook